MARKET

NWPN

NWPN

Now Corp
OTCPK
0.0001
0.0000
0.00%
Closed 14:19 03/21 EDT
OPEN
0.0001
PREV CLOSE
0.0001
HIGH
0.0001
LOW
0.0001
VOLUME
60.10K
TURNOVER
6
52 WEEK HIGH
0.0002
52 WEEK LOW
0.0001
MARKET CAP
612.33K
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NWPN last week (0310-0314)?
Weekly Report · 4d ago
The Now Corporation announces plan to reduce debt
Seeking Alpha · 03/10 12:45
Press Release: The Now Corporation Prioritizes Debt Reduction
Dow Jones · 03/10 12:33
Weekly Report: what happened at NWPN last week (0303-0307)?
Weekly Report · 03/10 09:44
Weekly Report: what happened at NWPN last week (0224-0228)?
Weekly Report · 03/03 09:43
Weekly Report: what happened at NWPN last week (0217-0221)?
Weekly Report · 02/24 09:43
The Now Corporation launches joint venture with Chronical Engineering
Seeking Alpha · 02/18 14:25
Weekly Report: what happened at NWPN last week (0210-0214)?
Weekly Report · 02/17 09:42
More
About NWPN
The Now Corporation is a biopharmaceutical research company committed to advancing the science of cannabis research. The Company is focused on the research, education and production of scientific grade cannabidiol and tetrahydrocannabinol medicine. It serves the cannabis industry across the United States and Canada. Its subsidiary, The Now Agency is dedicated to offering content creators on platforms, such as OnlyFans, Patreon, and Fansly support and opportunities for financial success and public recognition. The Company also owns Monster Elixir Inc.

Webull offers Now Corp stock information, including OTCPK: NWPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NWPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NWPN stock methods without spending real money on the virtual paper trading platform.